ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

MEDITECH Earns Best in KLAS Recognition for the 10th Consecutive Year

Expanse ranks first in two segments and in the top two for Overall Software Suite

MEDITECH’s Expanse platform continues its strong standing atop the KLAS leaderboard, ranking first for Acute Care EHR: Small (1-150 beds) and Patient Accounting and Patient Management: Small (1-150 beds) in the 2024 Best in KLAS: Software & Services report. 2024 is the fifth consecutive year that Expanse took the top spot in the Acute Care EHR (1-150 bed) segment, and the tenth consecutive year MEDITECH has been recognized as Best in KLAS by the global research firm.

“At KLAS, we firmly believe that the voice of healthcare providers and payers is paramount,” said KLAS Research CEO Adam Gale. “The Best in KLAS awards are based on extensive feedback and evaluations from healthcare professionals across the nation. Winning a Best in KLAS award, therefore, is not just about recognition; it shows the trust and confidence that healthcare providers place in the winning vendors. It also helps validate each vendor’s commitment to innovation, quality, and customer satisfaction. We are proud to recognize 2024’s Best in KLAS award winners! Their unwavering dedication to improving patient outcomes is wonderfully inspiring.”

MEDITECH continues to solidify its spot as one of the two leading EHR vendors in the industry by securing a top-two position in the Overall Software Suite rankings for the third consecutive year— a testament to the platform’s ability to consistently stay ahead of the rapid pace of EHR market movement. MEDITECH also ranked in the top two for the Midsize (151- 400 bed) segments for Acute Care EHR and Patient Accounting and Patient Management.

One CIO surveyed sees Expanse as a big win for clinician efficiency, stating, “The MEDITECH system is a more efficient and consistent and cleaner way of delivering information to the end user. In the past, we were in and out of modules and screens, and now everything is collected in a way that end users can very easily, with very few clicks, see the relevant information. It presents itself well and helps clinicians make decisions quicker. Our expectations of what the MEDITECH system would deliver are being hit.” (August, 2023).

MEDITECH’s Ambulatory solution also continues to outperform longer-standing solutions on the market, ranking in the top two for Ambulatory EHR (Health System Owned) for the third consecutive year. Physicians, in particular, appreciate Expanse’s web-based workflow and physician-driven design, with one CMIO stating, “MEDITECH’s web-based product is very good, and the user interface is very user friendly and can be picked up pretty easily. I like that MEDITECH has allowed us to be part of development and that we see a lot of other providers who are also part of product development. Basically, I can see MEDITECH’s product being developed, and the vendor is receiving input from providers who actually are using the system in day-to-day practice.” (September, 2023).

MEDITECH Executive Vice President and COO Helen Waters sees the clinician-centered design behind Expanse as a critical driver for the platform’s rapid rise. “Clinicians are eager for a solution that will match the everyday experience they get from their smartphone apps,” she explains.

“As an industry, we have a golden opportunity to leverage EHRs to transform how we care for patients and support providers. Yet, many healthcare organizations are still investing in EHRs rooted in 20th-century technology that has long disappeared from other industries. We are so proud of our steps in designing Expanse as an intelligent EHR for the modern world.

As more healthcare organizations begin to deploy our latest innovations in precision medicine, AI, and mobility, we are confident that our strategy to lean into the changes happening in this new era of digital healthcare will bring about the true transformation the industry needs. We remain committed to supporting our customers, delivering sophisticated capabilities, and staying laser-focused on delivering sustainable value to support our healthcare delivery system.”

MEDITECH will showcase its latest Expanse innovations at the upcoming ViVE (Booth # 1524) and HIMSS (Booth # 2580) conferences.

About MEDITECH

MEDITECH empowers healthcare organizations around the globe to expand their vision of what’s possible with Expanse, the world’s most intelligent EHR platform. Expanse answers the demands of an overburdened workforce: personalized workflows, intuitive functionality, interoperable systems, and innovative AI applications, all working together to drive better outcomes. See why thousands of healthcare organizations in 27 countries and territories choose Expanse. Visit ehr.meditech.com and follow us on X/Twitter, Facebook, LinkedIn, and Threads.

About KLAS

KLAS is a research and insights firm on a global mission to improve healthcare. Working with thousands of healthcare professionals and clinicians, KLAS gathers data and insights on software and services to deliver timely reports and performance data that represent provider and payer voices and act as catalysts for improving vendor performance. The KLAS research team publishes reports covering the most pressing questions facing healthcare technology today, including emerging technology insights, that provide early insights on the future of healthcare technology solutions. KLAS also fosters measurement and collaboration between healthcare providers and payers and best practice adoption. Learn more at klasresearch.com.

MEDITECH earns Best in KLAS recognition for the 10th consecutive year. #Expanse ranks first in two segments and in the top two for Overall Software Suite. @MEDITECH #BestinKLAS #BestinKLASAwards #BIK2024 @KLASresearch

Contacts

Jason Patnode

Manager, Content, Branding, and Digital Marketing

MEDITECH

781-774-5746

jpatnode@meditech.com

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.